Pharma Marketing News Vol. 10, No. 15: 12 October 2011
Welcome to Volume 10, Issue #15 (12 OCTOBER 2011) of Pharma Marketing News.
Without Free Gifts from Pharma to Docs, Would Research be Useless?
In a recent blog post (here), PhRMA said "Without Promotion Research will be Useless." To support its case, PhRMA cited "an interesting opinion editorial"...
In Memory of Steve Jobs Will Novartis Sales Reps Really Embrace iPads?
Pharmalot reported today that "In a memo this morning, David Epstein, who heads Novartis Pharmaceuticals, wrote that before the end of next year, more...
2nd Annual Pharmaguy Social Media Pioneer Award Goes to…
Readers of Pharma Marketing Blog may recall that last year I presented the first ever "Pharmaguy Social Media Pioneer Award" to Alex Butler, Digital...
Chris Viehbacher, PhRMA’s Chairman, Masters the Art of “Proofiness”
I just started reading the book "Proofiness: The Dark Arts of Mathematical Deception" by Charles Seife. The book promises to "conduct a thorough investigation...
BI’s Famously Unpronounceable Video Lives On!
A day or two after I posted my impression of Boehringer's (BI's) new YouTube video that spoofs efforts to pronounce the company's name through...
The Big C in the Big Apple
I just received this tweet from Fabio Gratton (@skypen), Co-founder & Chief Innovation Officer of Ignite Health: "Have you seen the C in NYC?...
Pharma’s Physician Bailout
The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.?
Pharma’s Physician Bailout
The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.?
Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
